Recombinant Human ADM2 Protein，His

ADM2, also known as Adrenomedullin 2, is a member of the adrenomedullin family of peptides that plays a crucial role in various physiological processes, including vascular regulation, inflammation, and tissue homeostasis. Its discovery and characterization have sparked significant interest in understanding its potential therapeutic implications, particularly in cardiovascular and metabolic disorders. Research indicates that ADM2 possesses vasodilatory effects, promoting endothelial function and influencing blood pressure regulation. Furthermore, studies suggest that ADM2 may be involved in tissue repair and regenerative processes, indicating its potential role in combating ischemic injuries and promoting wound healing. Given the complex interplay of ADM2 in various signaling pathways, scientists are increasingly focused on recombinant protein expression systems to produce ADM2 for functional studies and drug development. These investigations aim to delineate the specific mechanisms by which ADM2 exerts its biological effects and explore its viability as a biomarker or target for therapeutic intervention in diseases characterized by vascular dysfunction and inflammation. Overall, the characterization and study of recombinant ADM2 offer promising avenues for advancing our understanding of its biological significance and potential clinical applications.